Related Experiment Videos
[The efficacy of midazolam-famotidine suppository for premedication in children]
Insights
Midazolam-famotidine suppositories effectively reduced gastric volume and increased gastric pH in pediatric patients undergoing surgery. This novel formulation offers a potentially effective alternative for pediatric premedication.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
- Gastroenterology
Background:
- Premedication in pediatric surgery aims to reduce anxiety and optimize gastric conditions.
- Current premedication strategies may have variable effects on gastric volume and pH.
- Ensuring adequate gastric pH and minimal volume is crucial for patient safety during anesthesia.
Purpose of the Study:
- To evaluate the efficacy of a midazolam-famotidine suppository (M-F suppository) as a premedicant in pediatric patients.
- To compare the effects of the M-F suppository with intramuscular hydroxyzine on gastric parameters.
- To assess the sedative efficacy of the M-F suppository.
Main Methods:
- A prospective study involving pediatric patients (5 months to 7 years) scheduled for minor elective surgery.
- Patients received either an M-F suppository (midazolam 0.5 mg/kg and famotidine 2 mg/kg) or an intramuscular injection of hydroxyzine (1 mg/kg).
- Gastric pH and volume were measured in both groups.
Main Results:
- The M-F suppository group exhibited significantly higher gastric pH (3.90 ± 0.34) compared to the intramuscular injection group (1.82 ± 0.15).
- Gastric volume was significantly lower in the M-F suppository group (1.88 ± 0.54 ml) than in the intramuscular injection group (8.42 ± 1.76 ml).
- The M-F suppository demonstrated comparable sedative effects to intramuscular hydroxyzine.
Conclusions:
- The midazolam-famotidine suppository is an effective premedicant for pediatric patients.
- The M-F suppository favorably alters gastric parameters, potentially improving safety during anesthesia.
- This formulation presents a viable alternative to traditional intramuscular premedication in pediatric surgical settings.
Abstract:
We evaluated the efficacy of midazolam-famotidine suppository (M-F suppository) for premedication in children. After obtaining informed parental consent, we studied children aged 5m-7y, ASA I status, scheduled for minor elective surgery. The suppository group (n = 26) was given suppository of both midazolam 0.5 mg.kg-1 and famotidine 2 mg.kg-1, and the intramuscular injection group (n = 19) was given hydroxyzine 1 mg.kg-1. In the suppository group, gastric pH (3.90 +/- 0.34) was significantly higher, and gastric volume (1.88 +/- 0.54 ml) was significantly less than in the intramuscular injection group (1.82 +/- 0.15, 8.42 +/- 1.76 ml). The M-F suppository may offer similar sedative effect as an intramuscular injection of hydroxyzine. We concluded that the M-F suppository is an effective premedicant for pediatric patients.